General Court agrees with pharma complaint rejection despite error
The EU General Court has found that the European Commission acted legally when it ultimately rejected a complaint alleging anticompetitive dual pricing in the pharmaceutical market, despite it misinterpreting a previous judgment on the enforcer’s 2001 decision.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.